We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 278 results
  1. Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies

    Quercetin is a polyphenolic bioactive compound highly enriched in dietary fruits, vegetables, nuts, and berries. Quercetin and its derivatives like...

    Chandra Prakash, Jyoti Tyagi, ... Deepak Sharma in NeuroMolecular Medicine
    Article 11 August 2022
  2. Pharmacoresistance in Epilepsy

    Although more than 30 anti-seizure medications are available on the market, epilepsy remains pharmaco-resistant in 30% of patients with focal...
    Daniel San-Juan, Roberto Antonio Cordova Peralta in Pharmacoresistance in Epilepsy
    Chapter 2023
  3. GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture

    Epilepsy is a highly heritable disorder affecting over 50 million people worldwide, of which about one-third are resistant to current treatments....

    Remi Stevelink, Ciarán Campbell, ... Quratulain Zulfiqar Ali in Nature Genetics
    Article Open access 31 August 2023
  4. Noninvasive Brain Stimulation as a Potential Therapeutic Procedure in Drug-Resistant Epilepsy

    About only 5% of all patients with drug-resistant epilepsy can be considered candidates for surgery. Consequently, there is an enhancing interest in...
    Lilia Morales-Chacón, Lazaro Gómez-Fernández in Pharmacoresistance in Epilepsy
    Chapter 2023
  5. Schisandrin B, a dual positive allosteric modulator of GABAA and glycine receptors, alleviates seizures in multiple mouse models

    Epilepsy is a prevalent and severe neurological disorder and approximately 30% of patients are resistant to existing medications. It is of utmost...

    Jun Wu, Miao Zhao, ... Hai-bo Yu in Acta Pharmacologica Sinica
    Article 28 November 2023
  6. Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus

    A ketogenic diet (KD) is a high-fat, low-carbohydrate, and low-protein diet that exerts antiepileptic effects by attenuating spontaneous recurrent...

    Bianli Li, Yue Ma, ... Yuanyuan Qiang in Neurochemical Research
    Article 27 June 2024
  7. Immunosuppressant Tacrolimus Treatment Delays Acute Seizure Occurrence, Reduces Elevated Oxidative Stress, and Reverses PGF2α Burst in the Brain of PTZ-Treated Rats

    It is still an urgent need to find alternative and effective therapies to combat epileptic seizures. Tacrolimus as a potent immunosuppressant and...

    Burcu Azak Pazarlar, Cansu Bilister Egilmez, ... Oytun Erbas in Neurochemical Research
    Article 13 February 2023
  8. Sleep and Epilepsy

    In people with epilepsy, sleep may be disrupted by nocturnal epileptic activity as well as by the use of antiseizure medications (ASM). Conversely...
    Francesca Furia, Maria Paola Canevini, Elena Zambrelli in Sleep and Neuropsychiatric Disorders
    Chapter 2022
  9. Transporter Hypothesis in Pharmacoresistant Epilepsies: Is it at the Central or Peripheral Level?

    The multidrug resistance (MDR) phenotype characterizes patients with refractory epilepsy (RE). Seizures are not controlled despite receiving various...
    Liliana Czornyj, Jerónimo Auzmendi, Alberto Lazarowski in Pharmacoresistance in Epilepsy
    Chapter 2023
  10. Experimental Models for the Study of Drug-Resistant Epilepsy

    Drug-resistant epilepsy is a major health problem that has not diminished despite the existence of new antiepileptic drugs. The use of appropriate...
    Monserrat Fuentes-Mejia, Angeles Nuñez-Lumbreras, ... Luisa L. Rocha in Pharmacoresistance in Epilepsy
    Chapter 2023
  11. Ketogenic Diet and Drug-Resistant Epilepsy

    The ketogenic diet is a high-fat, low-carbohydrate, and restricted protein diet that is used in children with drug-resistant epilepsy. Over the past...
    Roberto Caraballo in Pharmacoresistance in Epilepsy
    Chapter 2023
  12. Drug-Resistant Epilepsy and the Influence of Age, Gender, and Comorbid Disorders

    In the study of drug-resistant epilepsy (DRE), certain important characteristics remain poorly understood such as the age and gender of patients and...
    Jesús Servando Medel-Matus, César Emmanuel Santana-Gómez, Ángel Alberto Puig-Lagunes in Pharmacoresistance in Epilepsy
    Chapter 2023
  13. Modulating P-glycoprotein Regulation as a Therapeutic Strategy for Pharmacoresistant Epilepsy

    Experimental data suggest a role of blood–brain barrier P-glycoproteinP-glycoprotein (P-gp) overexpression as a factor contributing to drug-resistant...
    Daniel Perez-Perez, Hiram Luna-Munguia, Heidrun Potschka in Pharmacoresistance in Epilepsy
    Chapter 2023
  14. Screening Platforms for Genetic Epilepsies—Zebrafish, iPSC-Derived Neurons, and Organoids

    Recent advances in molecular and cellular engineering, such as human cell reprogramming, genome editing, and patient-specific organoids, have...

    Aleksandr Shcheglovitov, Randall T. Peterson in Neurotherapeutics
    Article 01 July 2021
  15. Physical Exercise as a Strategy to Reduce Seizure Susceptibility

    Neuroprotective and antiepileptogenic therapies have been extensively used for prevention and treatment of epilepsy. This chapter focuses on the...
    Ricardo Mario Arida in Pharmacoresistance in Epilepsy
    Chapter 2023
  16. Impact of REM Sleep on Sleep Disorders: Current Perspectives

    Sleep is a complex process characterized by different stages, including rapid eye movement (REM) and non-rapid eye movement (NREM) sleep. Throughout...
    Ahmed S. BaHammam, Mahadevappa Hunasikatti, Seithikurippu R. Pandi-Perumal in Sleep Apnea Frontiers
    Chapter 2023
  17. Effects of Transcranial Focal Electrical Stimulation Via Concentric Ring Electrodes on Seizure Activity

    Epilepsy affects approximately one percent of the planet’s population. There does not appear to be any single therapy that works for all types of...
    Walter G. Besio in Pharmacoresistance in Epilepsy
    Chapter 2023
  18. Vagus Nerve Stimulation for Intractable Seizures

    Vagus nerve stimulation (VNS) is the most widely used non-pharmacological treatment for drug-resistant epilepsy (DRE) since its approval by the FDA...
    Mario A. Alonso Vanegas in Pharmacoresistance in Epilepsy
    Chapter 2023
  19. Iron and Epilepsy

    Epilepsy is a disorder defined by repeated, recurrent, and temporary impairment of the brain (CNS) caused by an abnormally rhythmic discharge of...
    Rajesh Thangarajan, Pugazhandhi Bakthavatchalam in Brain-Iron Cross Talk
    Chapter 2023
  20. Effect of a Ketogenic Diet on Oxidative Posttranslational Protein Modifications and Brain Homogenate Denaturation in the Kindling Model of Epilepsy in Mice

    This study focused on the ketogenic diet (KD) effects on oxidative posttranslational protein modification (PPM) as presumptive factors implicated in...

    Pavlina Andreeva-Gateva, Zafer Sabit, ... Boris Tenchov in Neurochemical Research
    Article 22 March 2022
Did you find what you were looking for? Share feedback.